カテゴリ： GlobalData, アメリカ, 企業調査

GE Healthcare LLC-製薬・医療分野：企業M&A・提携分析

◆英語タイトル：GE Healthcare LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA8014341
◆発行会社（調査会社）：GlobalData
◆発行日：2017年11月22日
◆ページ数：79
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cellular technologies; imaging agents used during medical scanning procedures; and a range of healthcare IT solutions. GE Healthcare also provides services such as performance improvement and performance solutions services, computerized data management and remote diagnostic and repair services of medical equipment manufactured by the company and others. The company conducts its operations across the world through subsidiaries and affiliates. GE Healthcare is headquartered in Chicago, Illinois, the US.

GE Healthcare LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
GE Healthcare LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
GE Healthcare LLC, Medical Devices Deals, 2011 to YTD 2017 11
GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
GE Healthcare LLC, Pharmaceuticals & Healthcare, Deal Details 15
Asset Purchase 15
GE Healthcare Acquires Rights to Rapiscan from Rapidscan Pharma Solutions 15
GE Healthcare Completes Acquisition Of Cell Culture, Gene Modulation And Magnetic Beads Businesses Of Thermo Fisher Scientific For US$1.06 Billion 16
Venture Financing 17
Monica Healthcare Raises USD3 Million in Venture Financing 17
Partnerships 19
Asymptote Enters into Licensing Agreement with Cell and Gene Therapy Catapult 19
Axiogenesis Enters into Licensing Agreement with GE Healthcare 20
Golden Meditech Enters into Partnership Agreement with GE Healthcare 21
GE Healthcare and Zai Lab Enter into Agreement 22
Bird Rock Bio Enters into agreement with GE Healthcare 23
Synpromics Enters into Research Agreement with GE Healthcare 24
Boston Children’s Hospital Enters into Agreement with GE Healthcare 25
GE Healthcare Enters into Agreement with National Industrial Clusters Development Program, SaudiVax and King Saud University 26
Cell Therapy Catapult Enters into Agreement with Asymptote 27
GE Healthcare Enters into R&D Agreement with Takeda Pharma 28
GE Healthcare Enters Into R&D Agreement With Healthcare Technology Innovation Centre 29
GE Healthcare Enters Into Agreement With Eurofins Panlabs For Drug Discovery 30
GE Healthcare Enters Into Agreement With HealthTrust To Provide Infant Care Solutions 31
GE Healthcare Enters Into Research Agreement With University of Wisconsin For Medical Imaging And Diagnostics 32
GE Healthcare Life Sciences Enters Into Commercialization Agreement With NetBio 33
Ibio Enters Into Agreement With GE Healthcare To Commercialize Plant-Based Technologies 34
GE Healthcare Enters Into Co-Development Agreement With Beijing Genomics Institute 35
Microsoft and GE Healthcare Form Joint Venture 36
Karolinska University Hospital Enters Into Research Agreement With GE Healthcare For Cell Therapy 37
Maine Manufacturing Enters Into Co-Marketing Agreement With GE Healthcare 38
Nueclear Healthcare Enters Into Agreement With GE Healthcare To Establish Molecular Imaging Centres 39
NIBRT Enters Into Co-Development Agreement With GE Healthcare Life Sciences 40
Gyros Expands Distribution Agreement With GE Healthcare Life Sciences 41
Rapidscan Pharma Enters Into Distribution Agreement With GE Healthcare For Rapiscan 42
Licensing Agreements 43
GE Healthcare Enters into Licensing Agreement with StemCell Technologies 43
GE Healthcare Enters into Licensing Agreement with Promosome 44
Blue Earth Diagnostics Enters Into Licensing Agreement With GE Healthcare For Fluciclovine 45
Merck Enters Into Licensing Agreement With GE Healthcare For Flutemetamol 46
GE Healthcare Life Sciences Enters Into Licensing Agreement With Cellular Dynamics For Cellular Assays And Models 47
GE Healthcare Expands Licensing Agreement With Geron For Stem Cell Assays 48
GE Healthcare Enters Into Licensing Agreement With Dyax For c-Met Imaging Peptides 49
GE Healthcare Life Sciences Enters Into Licensing Agreement With Affitech 50
Sartorius Stedim Biotech Enters Into Licensing Agreement With GE Healthcare 51
GE Healthcare Enters Into Licensing Agreement With Sartorius Stedim Biotech 52
Asset Transactions 53
Maine Manufacturing Acquires Laboratory Product Lines Of GE Healthcare 53
Maine Manufacturing Acquires Laboratory Filter and Membrane Business Of GE Healthcare 54
Acquisition 55
GE Healthcare Acquires Novia Strategies 55
Biosafe Acquires Biosafe Brasil Distribuidora from ACTS do Brasil 56
GE Healthcare Completes Acquisition Of Xcellerex, Bimolecular Manufacturing Technology Company 57
IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences 59
GE Healthcare Completes Acquisition Of PAA Labs 60
GE Healthcare Completes Acquisition Of Applied Precision 61
GE Healthcare LLC – Key Competitors 62
GE Healthcare LLC – Key Employees 63
GE Healthcare LLC – Locations And Subsidiaries 65
Head Office 65
Other Locations & Subsidiaries 65
Joint Venture 68
Recent Developments 70
Strategy And Business Planning 70
Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 70
Corporate Communications 71
Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 71
Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 72
Mar 09, 2016: Charles Koontz Appointed President and CEO of GE Healthcare IT and GE Healthcare Chief Digital Officer 73
Product News 74
Sep 05, 2017: GE Healthcare advances the delivery of cell therapies with new thawing technology 74
Jun 13, 2016: GE Healthcare launches next generation Biacore molecular interaction analysis platform 75
Other Significant Developments 76
Feb 20, 2017: Phreesia Selected as a Member of GE Healthcare’s Centricity Partner Program 76
May 31, 2016: GE Healthcare joins high-profile vaccine collaboration to explore vaccine self-sufficiency and pandemic preparedness in Saudi Arabia as part of 2030 Vision 77
Jan 13, 2016: GE Healthcare, FedDev Ontario commit CAD $40M for new CCRM-led centre to solve cell therapy manufacturing challenges 78
Appendix 79
Methodology 79
About GlobalData 79
Contact Us 79
Disclaimer 79

List of Tables
GE Healthcare LLC, Pharmaceuticals & Healthcare, Key Facts, 2016 2
GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
GE Healthcare LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
GE Healthcare LLC, Deals By Therapy Area, 2011 to YTD 2017 10
GE Healthcare LLC, Medical Devices Deals, 2011 to YTD 2017 11
GE Healthcare LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
GE Healthcare Acquires Rights to Rapiscan from Rapidscan Pharma Solutions 15
GE Healthcare Completes Acquisition Of Cell Culture, Gene Modulation And Magnetic Beads Businesses Of Thermo Fisher Scientific For US$1.06 Billion 16
Monica Healthcare Raises USD3 Million in Venture Financing 17
Asymptote Enters into Licensing Agreement with Cell and Gene Therapy Catapult 19
Axiogenesis Enters into Licensing Agreement with GE Healthcare 20
Golden Meditech Enters into Partnership Agreement with GE Healthcare 21
GE Healthcare and Zai Lab Enter into Agreement 22
Bird Rock Bio Enters into agreement with GE Healthcare 23
Synpromics Enters into Research Agreement with GE Healthcare 24
Boston Children's Hospital Enters into Agreement with GE Healthcare 25
GE Healthcare Enters into Agreement with National Industrial Clusters Development Program, SaudiVax and King Saud University 26
Cell Therapy Catapult Enters into Agreement with Asymptote 27
GE Healthcare Enters into R&D Agreement with Takeda Pharma 28
GE Healthcare Enters Into R&D Agreement With Healthcare Technology Innovation Centre 29
GE Healthcare Enters Into Agreement With Eurofins Panlabs For Drug Discovery 30
GE Healthcare Enters Into Agreement With HealthTrust To Provide Infant Care Solutions 31
GE Healthcare Enters Into Research Agreement With University of Wisconsin For Medical Imaging And Diagnostics 32
GE Healthcare Life Sciences Enters Into Commercialization Agreement With NetBio 33
Ibio Enters Into Agreement With GE Healthcare To Commercialize Plant-Based Technologies 34
GE Healthcare Enters Into Co-Development Agreement With Beijing Genomics Institute 35
Microsoft and GE Healthcare Form Joint Venture 36
Karolinska University Hospital Enters Into Research Agreement With GE Healthcare For Cell Therapy 37
Maine Manufacturing Enters Into Co-Marketing Agreement With GE Healthcare 38
Nueclear Healthcare Enters Into Agreement With GE Healthcare To Establish Molecular Imaging Centres 39
NIBRT Enters Into Co-Development Agreement With GE Healthcare Life Sciences 40
Gyros Expands Distribution Agreement With GE Healthcare Life Sciences 41
Rapidscan Pharma Enters Into Distribution Agreement With GE Healthcare For Rapiscan 42
GE Healthcare Enters into Licensing Agreement with StemCell Technologies 43
GE Healthcare Enters into Licensing Agreement with Promosome 44
Blue Earth Diagnostics Enters Into Licensing Agreement With GE Healthcare For Fluciclovine 45
Merck Enters Into Licensing Agreement With GE Healthcare For Flutemetamol 46
GE Healthcare Life Sciences Enters Into Licensing Agreement With Cellular Dynamics For Cellular Assays And Models 47
GE Healthcare Expands Licensing Agreement With Geron For Stem Cell Assays 48
GE Healthcare Enters Into Licensing Agreement With Dyax For c-Met Imaging Peptides 49
GE Healthcare Life Sciences Enters Into Licensing Agreement With Affitech 50
Sartorius Stedim Biotech Enters Into Licensing Agreement With GE Healthcare 51
GE Healthcare Enters Into Licensing Agreement With Sartorius Stedim Biotech 52
Maine Manufacturing Acquires Laboratory Product Lines Of GE Healthcare 53
Maine Manufacturing Acquires Laboratory Filter and Membrane Business Of GE Healthcare 54
GE Healthcare Acquires Novia Strategies 55
Biosafe Acquires Biosafe Brasil Distribuidora from ACTS do Brasil 56
GE Healthcare Completes Acquisition Of Xcellerex, Bimolecular Manufacturing Technology Company 57
IntegenX Acquires SV, Provider Of DNA Identification Consumable Products, From GE Healthcare Bio-Sciences 59
GE Healthcare Completes Acquisition Of PAA Labs 60
GE Healthcare Completes Acquisition Of Applied Precision 61
GE Healthcare LLC, Key Competitors 62
GE Healthcare LLC, Key Employees 63
GE Healthcare LLC, Other Locations 65
GE Healthcare LLC, Subsidiaries 65
GE Healthcare LLC, Joint Venture 68

★海外企業調査レポート[GE Healthcare LLC-製薬・医療分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • West Cornwall Pasty Co. Ltd：企業の戦略・SWOT・財務分析
    West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • DPR Construction Inc：企業の戦略的SWOT分析
    DPR Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Royal Mail Plc (RMG)：企業の財務・戦略的SWOT分析
    Royal Mail Plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Noble Corporation Plc (NE)：企業の財務・戦略的SWOT分析
    Noble Corporation Plc (NE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • TBC Corp：企業の戦略・SWOT・財務情報
    TBC Corp - Strategy, SWOT and Corporate Finance Report Summary TBC Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Beam Suntory Inc.：企業の戦略・SWOT・財務情報
    Beam Suntory Inc. - Strategy, SWOT and Corporate Finance Report Summary Beam Suntory Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Asian Citrus Holdings Ltd (73)：企業の財務・戦略的SWOT分析
    Asian Citrus Holdings Ltd (73) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Vivendi S.A.：戦略・SWOT・企業財務分析
    Vivendi S.A. - Strategy, SWOT and Corporate Finance Report Summary Vivendi S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Mattel, Inc (MAT)：企業の財務・戦略的SWOT分析
    Mattel, Inc (MAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • HealthTronics Inc：医療機器：M&Aディール及び事業提携情報
    Summary HealthTronics Inc (HealthTronics), a subsidiary of Altaris Capital Partners, LLC, carries out manufacturing, marketing and distribution of lithotripters, cryoblation devices and nerve monitoring equipment. The various products and services offered by the company include lithotripsy services, …
  • MEC Resources Ltd (MMR)：企業の財務・戦略的SWOT分析
    MEC Resources Ltd (MMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Opthea Ltd (OPT)-医療機器分野：企業M&A・提携分析
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd is a provider of research and development of angiogenesis and vascular leakage-based treatments for cancer focusing on vascular endothelial growth factors. The company’s pipeline products comprise VEGF-C, VEGF-D and VEGFR-3. Opthea’s d …
  • VivaCell Biotechnology Espana SL：製薬・医療：M&Aディール及び事業提携情報
    Summary VivaCell Biotechnology Espana SL (VivaCell Biotechnology), a subsidiary of VivaCell Biotechnology GmbH, is a preclinical-stage pharmaceutical company that develops medicinal derivatives. The company's products comprise CDE-001, VCE-003.2 and VCE-004.8. It provides research and development, c …
  • Allot Communications Ltd. (ALLT)：企業の財務・戦略的SWOT分析
    Allot Communications Ltd. (ALLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Mitsui O.S.K. Lines Ltd (9104)-石油・ガス分野：企業M&A・提携分析
    Summary Mitsui O.S.K. Lines Ltd (MOL) is a global marine logistic company. It owns and operates dry bulkers, tankers, LNG carriers, containerships, ferries & coastal RoRo ships, cruise ships. The company’s dry bulkers transport dry bulk cargo such as iron ore, coal, grains, wood, wood chips, cement, …
  • Community Trust Bancorp Inc：企業の戦略・SWOT・財務情報
    Community Trust Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Community Trust Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Banque Cantonale de Geneve Private Banking：企業の戦略・SWOT・財務情報
    Banque Cantonale de Geneve Private Banking - Strategy, SWOT and Corporate Finance Report Summary Banque Cantonale de Geneve Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • ACUTRONIC USA, Inc.：企業の戦略・SWOT・財務情報
    ACUTRONIC USA, Inc. - Strategy, SWOT and Corporate Finance Report Summary ACUTRONIC USA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Arbuthnot Latham & Co., Limited：企業の戦略・SWOT・財務情報
    Arbuthnot Latham & Co., Limited - Strategy, SWOT and Corporate Finance Report Summary Arbuthnot Latham & Co., Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • 21st Century Oncology Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary 21st Century Oncology Inc. (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services (ICC). It operates through an integrated network of cancer treatment centers and affiliated physicians with specialization in radiation o …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆